Evidence
The research is limited. It isn’t empty.
The record includes human studies, historical medical literature, laboratory chemistry, animal work, practitioner reports, safety cases, and adjacent research on coffee, bile, glutathione, and the liver.
01Rectal caffeine absorption
A randomized crossover study in eleven healthy men demonstrated caffeine absorption from a 4-gram, 500-millilitre coffee enema retained for ten minutes. Systemic caffeine exposure was lower than after the tested oral coffee.
Human pharmacokinetic studyRead the study →
02Selected antioxidant markers
A small study using the same low-dose preparation didn’t demonstrate improvement in the serum glutathione, total antioxidant capacity, or malondialdehyde measurements it selected. It didn’t measure bile flow, liver-tissue GST, bowel function, pain, nausea, or subjective relief.
Human intervention studyRead the record →
03Constipation series
An uncontrolled series of 42 patients reported improved constipation and defecation-frequency scores. With no control group, randomisation, blinding, or objective transit measurement, it remains a signal rather than a definitive trial.
Uncontrolled clinical series04Capsule-endoscopy preparation
A small pilot studied coffee enemas as part of bowel preparation before capsule endoscopy in people with chronic constipation. It concerned visualization and bile clearing, not proof of detoxification or liver treatment.
Human clinical pilotRead the study →
05Published safety reports
A systematic review assembled adverse-event case reports but couldn’t calculate incidence. Incident-level reading matters because excessive temperature, frequency, volume, infection risk, mechanical factors, and severe patient vulnerability aren’t the same causal claim.
Case-report reviewRead the safety analysis →
06Coffee, liver, and glutathione
Animal and oral-coffee research provides relevant biological context involving coffee compounds, glutathione, liver measures, and gallbladder contraction. These studies aren’t human coffee-enema efficacy trials.
Adjacent evidence